In this free webinar, learn about best practices for robust risk assessment and establishing key risk indicators (KRIs). Attendees will learn strategies for mitigating data quality challenges in neuroscience studies. The featured speakers will discuss the benefits of a clinical specialist conducting regular, blinded data reviews of study KRIs. Attendees will learn about the use and impact of technology in enhancing the risk detection process.
TORONTO, Ontario, July 6, 2023 /PRNewswire-PRWeb/ -- A new educational webinar is set to take the stage, addressing the significant challenges in neuroscience trials and offering strategies for enhancing success rates.
Neuroscience trials face unique difficulties due to the complexity of the brain, the most intricate organ in the body. These trials often struggle with the lack of reliable biomarkers, subjective outcome parameters and high placebo response rates. The webinar will explore these issues and discuss the role of early risk detection in increasing the chances of success in clinical studies.
Dr. Andreas Schreiner, MD, Senior Vice President of Medical Affairs, Neuroscience and Analgesia at Premier Research, and Adam Simmons, Executive Director of Program Strategy, Neuroscience at Premier Research, will share their knowledge and expertise in this event. The webinar aims to shed light on the key factors contributing to the failure of neuroscience trials and to offer effective risk detection strategies.
Premier Research, a global clinical research company, is committed to helping innovators transform life-changing ideas and breakthrough science into new medical treatments. The company leverages innovative technologies for smart study design and trial management, delivering clean and conclusive data to sponsors. Premier Research is devoted to addressing the unmet needs of patients across a broad range of medical conditions.
This event is the latest in a series of collaborations between Premier Research and Xtalks, reflecting their shared dedication to spreading knowledge and encouraging innovative thinking within the scientific and medical communities.
The live webinar, titled "Risk Detection in Neuroscience Trials: Are You Missing Early Warning Signs?" is scheduled for Thursday, July 20, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Risk Detection in Neuroscience Trials: Are You Missing Early Warning Signs?
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com
SOURCE Xtalks
Share this article